GU Cancer
Advertisement
The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting.
A team used an interpretive description approach to evaluate the self-management support intervention.
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
The personalized, stratified follow-up pathway is led by advanced nurse practitioners and general practitioners.
Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer.
A collaborative approach between nurses and caregivers may help improve quality of life in patients and caregivers.
The combination was evaluated in the phase II KEYNOTE-199 clinical trial, which included multiple cohorts.
The survey of oncology nurses identified 3 top areas of unmet needs of patients with GU cancers.
Learn how a team developed an online group cognitive rehabilitation program for survivors of prostate cancer.
The trial is the first to evaluate the combination of an ADC and a TKI in metastatic urothelial carcinoma.
Learn about a pilot study of a survivorship program that is currently enrolling men with advanced GU cancers.
The study showed that a certain starting dose of the ADC maximized the likelihood of response to treatment.
A new study evaluated how social determinants of health can affect the risk of death in patients with cancer.
Learn how a team implemented a nursing intervention based on the gratitude extension-construction theory.
EV-302/KEYNOTE-A39 investigators say these results support the combination as a new standard of care for certain patients.
A new study shows why it's critical to prioritize clear communication and patient participation in treatment planning.
More than 20% of patients in the study had 10 or more drug prescriptions, indicating a need for careful management.
The Omaha system is a standardized tool for nursing practice, documentation, and information management.
Researchers evaluated the treatment in a large cohort of patients from the GUARDIANS consortium.
Amy Marbaugh, RN, BSN, MS, of the Kidney Cancer Association, explains why it's critical to raise awareness.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.